Neoplasms, Hormone-Dependent
Recent clinical, regulatory, research and industry developments relating to this disease.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes3
- Aromatase Inhibitors1
- Neoadjuvant Therapy1
- Orchiectomy1
Leading journals4
- Cancer research1
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology1
- Journal of the National Cancer Institute1
- The New England journal of medicine1
Leading researchers8
- Alvarez I1
- Andersen J1
- André F1
- Bajetta E1
- Bertelli G1
- Bliss JM1
- Carpentieri M1
- Chen B1
Affiliations (unnormalised)4
- Imperial College and Charing Cross Hospital1
- The University of Texas M.D. Anderson Cancer Center1
- University of Washington School of Medicine1
- Uro-Oncology Clinic1
Disease biology
Key proteins & gene products studied in this disease. Number shows shared papers.
Related conditions
Diseases frequently studied alongside this one. Number shows shared papers.
Reference
Authoritative identity, definition & identifiers.
Certain tumors that 1, arise in organs that are normally dependent on specific hormones and 2, are stimulated or caused to regress by manipulation of the endocrine environment.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.